danger of semaglutide Researchers highlight the limitations and risks Important article in The Indian

As shortages resolve, regulators are less willing to tolerate parallel supply channels for approved drugs

Until the age of 12 years, it is advised to follow-up patients every two weeks

It is plausible to postulate that the first and second GSH molecule should interact during the reductive half-reaction of the dithiol mechanism with the 1st and 2nd glutathione-interaction site, respectively

When compared with the beneficial effects of these drugs on glucose metabolism, blood pressure, body weight and cardiovascular (and potentially even renal) endpoints, these agents have an overall beneficial risk/benefit-profile for treatment of patients with T2D